RxDoctor Payments Data

Lauren Tomes, DO

Family Medicine · Bridgeport, WVNPI 1013220060

Payments from drug & device makers

$3,254in general payments, 2019–2025

Across 198 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$589
  • Novo Nordisk$539
  • Astellas Pharma US Inc$266
  • Boehringer Ingelheim$255
  • Pfizer$189
  • Takeda Pharmaceuticals U.S.A., Inc.$177
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,08095%
  • Education$1745%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,254 in reported general payments places this provider in the 85th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$116,215
Medicare patients
298
Services billed
3,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide164$234,138
JardianceEmpagliflozin125$165,974
MounjaroTirzepatide47$63,611
XareltoRivaroxaban26$24,792
MyrbetriqMirabegron29$24,764
EliquisApixaban38$24,011
EntrestoSacubitril/Valsartan35$22,643
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$18,578
Spiriva HandihalerTiotropium Bromide16$16,949
FarxigaDapagliflozin Propanediol15$13,173
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog24$13,122
Breo ElliptaFluticasone/Vilanterol18$6,928
Repatha SureclickEvolocumab11$5,809
SymbicortBudesonide/Formoterol Fumarate15$5,416
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$4,470

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$539$234,138164 claims
Boehringer IngelheimJardiance$255$165,974125 claims
Lilly USA, LLCMounjaro$144$63,61147 claims
Johnson & JohnsonXarelto$88$24,79226 claims
Astellas Pharma US IncMyrbetriq$266$24,76429 claims
PfizerEliquis$189$24,01138 claims
NovartisEntresto$123$22,64335 claims
AstraZenecaFarxiga, Symbicort$157$18,58930 claims
GSKBreo Ellipta$68$6,92818 claims
AbbVieSynthroid$589$3,87163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Bridgeport

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →